265PDTEN-YEAR SAFETY AND EFFICACY ANALYSES OF THE BIG 02-98 PHASE III TRIAL WITH AN EXPLORATORY ANALYSIS ON THE ROLE OF KI67 IN PREDICTING BENEFIT OF ADJUVANT DOCETAXEL IN ER POSITIVE PATIENTS
Sonnenblick, A., Azim, H.A., De Azambuja, E., Francis, P., Nordenskjöld, B., Crown, J.P., Gutiérez, J., Quinaux, E., Mastropasqua, M.G., Ameye, L., Anderson, M., Lluch, A., Goldhirsch, A., Di Leo, A.,Volume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu327.13
Date:
September, 2014
File:
PDF, 40 KB
english, 2014